Location History:
- Gyeonggi-do, KR (2018)
- Daejeon, KR (2014 - 2019)
Company Filing History:
4 out of 20 
2 out of 2,613 
1 out of 321 
Years Active: 2014-2019
Title: Innovations of Wan Taek Im in Cancer Treatment
Introduction
Wan Taek Im is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of cervical cancer. With a total of five patents to his name, his work showcases a commitment to advancing medical science.
Latest Patents
One of Wan Taek Im's latest patents is a composition for preventing or treating cervical cancer that includes gypenoside LXXV. This invention provides a pharmaceutical composition that can be administered to subjects, excluding humans, for the prevention or treatment of cervical cancer. Additionally, it includes a health functional food composition and a feed composition, both featuring gypenoside LXXV as an active ingredient. Another significant patent involves a method for glycosylation of ginsenoside using a glycosyltransferase derived from Panax ginseng. This invention relates to a UDP-glycosyltransferase protein that has glycosylation activity for specific ginsenosides.
Career Highlights
Wan Taek Im has worked with prominent institutions such as the Intelligent Synthetic Biology Center and the Korea Advanced Institute of Science and Technology. His research and innovations have positioned him as a key figure in the field of synthetic biology and pharmaceutical development.
Collaborations
Some of his notable coworkers include Sun Chang Kim and Chang Hao Cui. Their collaborative efforts have contributed to the advancements in the research and development of innovative treatments.
Conclusion
Wan Taek Im's contributions to cancer treatment through his innovative patents highlight the importance of research in pharmaceuticals. His work continues to inspire advancements in medical science and offers hope for effective treatments against cervical cancer.